Elekta AB Gross Profit 2013-2026 | EKTAY
Elekta AB gross profit from 2013 to 2026. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
|
Elekta AB Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2026 | $666 |
| 2025 | $640 |
| 2024 | $638 |
| 2023 | $608 |
| 2022 | $612 |
| 2021 | $642 |
| 2020 | $637 |
| 2019 | $629 |
| 2018 | $573 |
| 2017 | $506 |
| 2016 | $548 |
| 2015 | $580 |
| 2014 | $712 |
| 2013 | $718 |
| 2012 | $640 |
|
Elekta AB Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2026-01-31 | $160 |
| 2025-10-31 | $163 |
| 2025-07-31 | $140 |
| 2025-04-30 | $200 |
| 2025-01-31 | $158 |
| 2024-10-31 | $149 |
| 2024-07-31 | $133 |
| 2024-04-30 | $173 |
| 2024-01-31 | $160 |
| 2023-10-31 | $154 |
| 2023-07-31 | $150 |
| 2023-04-30 | $185 |
| 2023-01-31 | $158 |
| 2022-10-31 | $137 |
| 2022-07-31 | $128 |
| 2022-04-30 | $169 |
| 2022-01-31 | $147 |
| 2021-10-31 | $165 |
| 2021-07-31 | $132 |
| 2021-04-30 | $167 |
| 2021-01-31 | $165 |
| 2020-10-31 | $164 |
| 2020-07-31 | $146 |
| 2020-04-30 | $174 |
| 2020-01-31 | $161 |
| 2019-10-31 | $157 |
| 2019-07-31 | $145 |
| 2019-04-30 | $201 |
| 2019-01-31 | $150 |
| 2018-10-31 | $153 |
| 2018-07-31 | $125 |
| 2018-04-30 | $180 |
| 2018-01-31 | $139 |
| 2017-10-31 | $146 |
| 2017-07-31 | $107 |
| 2017-04-30 | $179 |
| 2017-01-31 | $117 |
| 2016-10-31 | $119 |
| 2016-07-31 | $91 |
| 2016-04-30 | $184 |
| 2016-01-31 | $118 |
| 2015-10-31 | $140 |
| 2015-07-31 | $106 |
| 2015-04-30 | $175 |
| 2015-01-31 | $105 |
| 2014-10-31 | $135 |
| 2014-07-31 | $80 |
| 2014-04-30 | $248 |
| 2014-01-31 | $144 |
| 2013-10-31 | $160 |
| 2013-07-31 | $122 |
| 2013-04-30 | $271 |
| 2013-01-31 | $165 |
| 2012-10-31 | $174 |
| 2012-07-31 | $106 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.906B | $1.781B |
| Elekta AB is a human care company engaged in developing and selling clinical solutions for the treatment of cancer and neurological diseases. It develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. The Company's offering is divided into five areas: Neuroscience, Oncology, Software, Brachytherapy and Services. Elekta AB is headquartered in Stockholm, Sweden. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $240.872B | 27.34 |
| Intuitive Surgical (ISRG) | United States | $138.955B | 47.11 |
| Edwards Lifesciences (EW) | United States | $50.820B | 31.41 |
| IQVIA Holdings (IQV) | United States | $43.853B | 23.45 |
| Waters (WAT) | United States | $41.424B | 30.82 |
| IDEXX Laboratories (IDXX) | United States | $40.308B | 35.98 |
| DexCom (DXCM) | United States | $33.717B | 35.04 |
| Alcon (ALC) | Switzerland | $32.170B | 19.95 |
| Mettler-Toledo (MTD) | United States | $27.898B | 31.02 |
| STERIS (STE) | Ireland | $19.991B | 19.68 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.827B | 0.00 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $14.536B | 17.43 |
| Penumbra (PEN) | United States | $12.510B | 82.49 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.924B | 8.35 |
| Globus Medical (GMED) | United States | $9.946B | 15.06 |
| Glaukos (GKOS) | United States | $9.662B | 0.00 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| SARTORIUS (SSSGY) | Germany | $7.521B | 43.67 |
| Sysmex ADR (SSMXY) | Japan | $7.434B | 28.12 |
| Teleflex (TFX) | United States | $5.276B | 14.23 |
| LivaNova (LIVN) | United Kingdom | $4.298B | 21.73 |
| Integer Holdings (ITGR) | United States | $4.293B | 19.89 |
| Pulse Biosciences (PLSE) | United States | $3.814B | 0.00 |
| Veracyte (VCYT) | United States | $3.199B | 26.18 |
| TransMedics (TMDX) | United States | $2.987B | 43.87 |
| AxoGen (AXGN) | United States | $2.378B | 0.00 |
| UFP Technologies (UFPT) | United States | $2.143B | 27.05 |
| Nihon Kohden (NHNKY) | Japan | $1.687B | 15.45 |
| Alphatec Holdings (ATEC) | United States | $1.572B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $1.377B | 0.00 |
| OPKO Health (OPK) | United States | $1.246B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.184B | 6.16 |
| Tandem Diabetes Care (TNDM) | United States | $1.174B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.171B | 27.77 |
| Artivion (AORT) | United States | $1.138B | 43.24 |
| PROCEPT BioRobotics (PRCT) | United States | $1.105B | 0.00 |
| IRadimed (IRMD) | United States | $1.050B | 45.88 |
| Beta Bionics (BBNX) | United States | $0.985B | 0.00 |
| SiBone (SIBN) | United States | $0.802B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.795B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.708B | 17.05 |
| AngioDynamics (ANGO) | United States | $0.638B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.570B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.559B | 1611.00 |
| Tactile Systems Technology (TCMD) | United States | $0.503B | 20.56 |
| NeuroPace (NPCE) | United States | $0.490B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.442B | 0.00 |
| 908 Devices (MASS) | United States | $0.435B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.426B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.422B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.355B | 0.00 |
| Mobia Medical (MOBI) | United States | $0.351B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Treace Medical Concepts (TMCI) | United States | $0.292B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.242B | 0.00 |
| Neuronetics (STIM) | United States | $0.221B | 0.00 |
| RxSight (RXST) | United States | $0.216B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.160B | 0.00 |
| FocalTherics (FOCL) | France | $0.156B | 0.00 |
| Inogen (INGN) | United States | $0.136B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| LENSAR (LNSR) | United States | $0.087B | 0.00 |
| Hyperfine (HYPR) | United States | $0.083B | 0.00 |
| CVRx (CVRX) | United States | $0.081B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.076B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.073B | 24.09 |
| DarioHealth (DRIO) | United States | $0.071B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.058B | 0.00 |
| Positron (POSC) | United States | $0.058B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.056B | 0.00 |
| Envoy Medical (COCH) | United States | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Vaso (VASO) | United States | $0.052B | 29.49 |
| Sensus Healthcare (SRTS) | United States | $0.050B | 0.00 |
| Precision Optics (POCI) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.044B | 0.00 | |
| QT Imaging Holdings (QTI) | United States | $0.036B | 0.00 |
| InspireMD (NSPR) | United States | $0.036B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| PAVmed (PAVM) | United States | $0.032B | 0.00 |
| Accuray (ARAY) | United States | $0.028B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.011B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| NexGel (NXGL) | United States | $0.003B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |